MA29084B1 - Derives d'indenyle et leur utilisation dans le traitement de troubles neurologiques - Google Patents
Derives d'indenyle et leur utilisation dans le traitement de troubles neurologiquesInfo
- Publication number
- MA29084B1 MA29084B1 MA29968A MA29968A MA29084B1 MA 29084 B1 MA29084 B1 MA 29084B1 MA 29968 A MA29968 A MA 29968A MA 29968 A MA29968 A MA 29968A MA 29084 B1 MA29084 B1 MA 29084B1
- Authority
- MA
- Morocco
- Prior art keywords
- treatment
- neurological disorders
- indenyl derivatives
- indenyl
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0426828A GB0426828D0 (en) | 2004-12-07 | 2004-12-07 | Novel compounds |
GB0519089A GB0519089D0 (en) | 2005-09-19 | 2005-09-19 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
MA29084B1 true MA29084B1 (fr) | 2007-12-03 |
Family
ID=36121490
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA29968A MA29084B1 (fr) | 2004-12-07 | 2007-06-06 | Derives d'indenyle et leur utilisation dans le traitement de troubles neurologiques |
Country Status (13)
Country | Link |
---|---|
US (1) | US20090306052A1 (fr) |
EP (1) | EP1833796A1 (fr) |
JP (1) | JP2008523006A (fr) |
KR (1) | KR20070091007A (fr) |
AU (1) | AU2005313550A1 (fr) |
BR (1) | BRPI0518841A2 (fr) |
CA (1) | CA2589831A1 (fr) |
IL (1) | IL183656A0 (fr) |
MA (1) | MA29084B1 (fr) |
MX (1) | MX2007006754A (fr) |
NO (1) | NO20073113L (fr) |
RU (1) | RU2007125648A (fr) |
WO (1) | WO2006061193A1 (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0513886D0 (en) | 2005-07-06 | 2005-08-10 | Glaxo Group Ltd | Novel compounds |
JP5203360B2 (ja) | 2006-06-23 | 2013-06-05 | アボット・ラボラトリーズ | ヒスタミンh3受容体調節剤としてのシクロプロピルアミン誘導体 |
US9108948B2 (en) | 2006-06-23 | 2015-08-18 | Abbvie Inc. | Cyclopropyl amine derivatives |
KR101571176B1 (ko) | 2007-11-13 | 2015-11-23 | 다이쇼 세이야꾸 가부시끼가이샤 | 페닐피라졸 유도체 |
TW201039822A (en) | 2009-02-06 | 2010-11-16 | Taisho Pharmaceutical Co Ltd | Dihydroquinolinone derivatives |
US9186353B2 (en) | 2009-04-27 | 2015-11-17 | Abbvie Inc. | Treatment of osteoarthritis pain |
WO2012037258A1 (fr) | 2010-09-16 | 2012-03-22 | Abbott Laboratories | Procédés de préparation de dérivés cyclopropyliques substitués en 1,2 |
KR20140100483A (ko) | 2011-12-08 | 2014-08-14 | 다이쇼 세이야꾸 가부시끼가이샤 | 페닐피롤 유도체 |
EP2799436A4 (fr) | 2011-12-27 | 2015-07-01 | Taisho Pharmaceutical Co Ltd | Dérivé de phényltriazole |
WO2013151982A1 (fr) | 2012-04-03 | 2013-10-10 | Arena Pharmaceuticals, Inc. | Méthodes et composés utiles pour traiter le prurit, et procédés d'identification desdits composés |
EP2647377A1 (fr) | 2012-04-06 | 2013-10-09 | Sanofi | Utilisation d'un antagoniste du récepteur h3 pour le traitement de la maladie d'Alzheimer |
CA3226162A1 (fr) | 2021-07-09 | 2023-01-12 | Plexium, Inc. | Composes aryle et compositions pharmaceutiques modulant l'ikzf2 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1545673A1 (de) * | 1965-05-13 | 1969-08-28 | Albert Ag Chem Werke | Verfahren zur Herstellung von pharmazeutisch wirksamen Derivaten des 2-Aminoindans |
US3943149A (en) * | 1972-11-10 | 1976-03-09 | E. R. Squibb & Sons, Inc. | Naphthyloxy acetic acids and related compounds |
WO1987002035A1 (fr) * | 1985-10-04 | 1987-04-09 | Maggioni-Winthrop S.P.A. | Aminoalcools cycloaliphatiques fusionnes |
US5708018A (en) * | 1993-08-06 | 1998-01-13 | Pharmacia & Upjohn Company | 2-aminoindans as selective dopamine D3 ligands |
US7399774B2 (en) * | 2003-03-07 | 2008-07-15 | Eli Lilly And Company | 6-substituted nicotinamide derivatives as opioid receptor antagonists |
-
2005
- 2005-12-05 EP EP05811338A patent/EP1833796A1/fr not_active Withdrawn
- 2005-12-05 WO PCT/EP2005/013070 patent/WO2006061193A1/fr active Application Filing
- 2005-12-05 RU RU2007125648/04A patent/RU2007125648A/ru not_active Application Discontinuation
- 2005-12-05 AU AU2005313550A patent/AU2005313550A1/en not_active Abandoned
- 2005-12-05 US US11/720,950 patent/US20090306052A1/en not_active Abandoned
- 2005-12-05 JP JP2007544807A patent/JP2008523006A/ja not_active Withdrawn
- 2005-12-05 MX MX2007006754A patent/MX2007006754A/es unknown
- 2005-12-05 BR BRPI0518841-5A patent/BRPI0518841A2/pt not_active Application Discontinuation
- 2005-12-05 KR KR1020077015530A patent/KR20070091007A/ko not_active Application Discontinuation
- 2005-12-05 CA CA002589831A patent/CA2589831A1/fr not_active Abandoned
-
2007
- 2007-06-04 IL IL183656A patent/IL183656A0/en unknown
- 2007-06-06 MA MA29968A patent/MA29084B1/fr unknown
- 2007-06-18 NO NO20073113A patent/NO20073113L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20073113L (no) | 2007-07-16 |
RU2007125648A (ru) | 2009-01-20 |
IL183656A0 (en) | 2007-09-20 |
MX2007006754A (es) | 2007-07-09 |
JP2008523006A (ja) | 2008-07-03 |
BRPI0518841A2 (pt) | 2008-12-09 |
EP1833796A1 (fr) | 2007-09-19 |
AU2005313550A1 (en) | 2006-06-15 |
WO2006061193A1 (fr) | 2006-06-15 |
US20090306052A1 (en) | 2009-12-10 |
KR20070091007A (ko) | 2007-09-06 |
CA2589831A1 (fr) | 2006-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA29084B1 (fr) | Derives d'indenyle et leur utilisation dans le traitement de troubles neurologiques | |
FR13C0060I2 (fr) | Omega-carboxyaryldiphenyluree fluoro-subtituee pour le traitement et la prevention de maladies et d'etats pathologiques | |
CY2013041I1 (el) | Φαρμακευτικες συνθεσεις περιλαμβανοντας δεξτρομεθορφανη και κινιδινη για την αγωγη νευρολογικων διαταραχων | |
GB0404693D0 (en) | Pharmaceutical preparations for the treatment of ocular surface and other disorders | |
MA28689B1 (fr) | Derives de pyrrozolotriazine utiles pour le traitement des troubles et maladies hyperproliferatifs associes a l'angiogenese | |
FR2854074B1 (fr) | Utilisation de l'ivermectine pour le traitement de desordres dermatologiques | |
NO20014524D0 (no) | Rekombinant IL-18 antagonister anvendelige i behandling av IL- 18 medierte forstyrrelser | |
PL1660458T3 (pl) | 2,4-pirymidynodwuaminy stosowane w leczeniu chorób nowotworowych, chorób zapalnych i zaburzeń układu immunologicznego | |
CY2015025I1 (el) | Μεθοδοι για την αντιμετωπιση της νοσου παρκινσον | |
IS8134A (is) | Píperasínafleiður og notkun þeirra til að meðhöndla tauga- og geðsjúkdóma | |
HK1109867A1 (en) | Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders | |
SI1835924T1 (sl) | Zdravljenje Parkinsonove bolezni in sorodnih obolenj z uporabo celic, pridobljenih post partum | |
ATE374204T1 (de) | Thienopyrimidinedione und deren verwendung in der behandlung von autoimmunerkrankungen | |
AU2003223579A8 (en) | Combinations of cox-2 inhibitors and other agents for the treatment of parkinson's disease | |
IL183772A0 (en) | Rapamycin derivatives and the uses thereof in the treatment of neurological disorders | |
IL181706A0 (en) | The treatment of inflammatory disorders and pain | |
NO20022680L (no) | Farmasoytiske kombinasjoner og deres anvendelse ved behandling av gastrointestinale forstyrrelser | |
NO20055136D0 (no) | Farmasoytisk sammensetning som innbeffatter et immunosuppressivt stoff for bruk ved behandling av hudsykdommer | |
NO20054913D0 (no) | Anvendelse av clustein for behandling og/eller forebyggelse av perifere nevrologiske lidelser | |
NO20031903L (no) | Nye amidoalkylpiperidin- og amidoalkylpiperazinderivater for anvendelse vedbehandling av nervesystemlidelser | |
NO20041833L (no) | Heterocykliske forbindelser for anvendelse i behandlingen av forstyrrelser i urinveissystemet | |
NO20034232D0 (no) | Anvendelse av glukokortikoid-reseptor-spesifikke antagonister ved behandling av stresslidelser | |
FR2812197B1 (fr) | Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches | |
IS6137A (is) | Meðhöndlun á hugsýkistruflunum | |
IL176453A0 (en) | Methods and compositions using thalidomide for the treatment and management of central nervous system disorders or diseases |